ask="40.50"
ask_size="700"
average_daily_volume="1413410"
bid="38.20"
bid_size="100"
book_value="11.83"
change="-0.12"
change_from_200_day_moving_average="-16.00"
change_from_50_day_moving_average="-2.32"
change_from_52_week_high="-41.24"
change_From_52_week_low="7.58"
change_in_percent="-0.31%"
close="38.96"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.55"
ebitda="-384.49M"
eps_estimate_current_year="-4.82"
eps_estimate_next_quarter="-1.33"
eps_estimate_next_year="-5.05"
ex_dividend_date="N/A"
float_shares="70877000"
high="39.22"
high_52_weeks="80.19"
last_trade_date="1/20/2017"
last_trade_price="38.96"
last_trade_size="56333"
last_trade_time="4:00pm"
low="38.02"
low_52_weeks="31.38"
market_capitalization="3.34B"
moving_average_200_day="54.96"
moving_average_50_day="41.28"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="63.36"
open="39.12"
pe_ratio="N/A"
peg_ratio="-0.17"
percent_change_from_200_day_moving_average="-29.11%"
percent_change_from_50_day_moving_average="-5.63%"
percent_change_from_52_week_high="-51.42%"
percent_change_from_52_week_low="+24.16%"
previous_close="39.08"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.30"
price_per_sales="90.01"
revenue="37.26M"
shares_outstanding="85813000"
short_ratio="5.47"
stock_exchange="NMS"
symbol="ALNY"
volume="817805"
weeks_range_52="31.38 - 80.19"
